Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial

Clinical trial NCT05277376 · COMPLETED

Trial details

NCT number: NCT05277376
Sponsor: dsm-firmenich Switzerland AG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pharmacokinetics Absorption; Chemicals

Start date: 2022-03-15
Primary completion: 2022-10-28
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.